Diagnosis

Erythema multiforme

An self-limiting immune-mediated hypersensitivity reaction affecting both the skin (target lesions on the extremities) and mucous membranes (eyes, mouth, or genitals).

Etiology

Cause [ugn][fnf][kqq]

  1. Virus:

    HSV-1, HSV-2, EBV, CMV, VZV, Adenovirus, Coxsackievirus, Echovirus, Hepatitis, Orf, Enterovirus, Hepatitis A/B/C viruses, Influenza, Measles, Mumps, Parvovirus B19, Poliomyelitis, HIV

  2. Bacteria:

    Mycoplasma pneumoniae, Corynebacterium diphtheriae, Hemolytic streptococci, Legionella pneumophila, Salmonella, Mycobacterium leprae, Pneumococcus, Borreliosis, Catscratch disease, Diphtheria, Legionellosis, Hemolytic streptococci, Staphylococcus, Leprosy, Salmonellosis, Neisseria meningitidis, Mycobacterium avium complex, Pneumococci, Tuberculosis, Treponema avium complex, pneumococci, tuberculosis, Treponema pallidum, tularemia, and rickettsia

  3. Fungus: Histoplasmosis

  4. Parasites

  5. Immune disease:

    Graft versus host disease, Inflammatory bowel disease, Polyarteritis nodosa, Sarcoidosis, Systemic lupus erythematous, Vaccines (Diphtheria-tetanus-pertussis, Measles-mumps-rubella, Bacille Calmette-Guerin, hepatitis B and smallpox)

  6. Drugs:

    Trimethoprim, sulfamethoxazole, NSAIDs, Penicillins, Anticonvulsants (barbiturates, carbamazepine), Hydantoids, Valproic acid, Allopurinol, Antifungal (Terbinafine), Oxicama (piroxicam, tenoxicam), Imidazole, Chlormezanone, Corticosteroids, Cephalosporins, Quinolones, Tetracycline, Aspirin, Nitrofurantoin, Diphtheria-tetanus-pertussis immunization, Measles-mumps-rubella vaccine

  7. Pregnancy

  8. Malignancy

  9. Radiotherapy

  10. Menstruation

  11. Idiopathic

Pathophysiology [kqq]

  1. Exact pathophysiology is unknown

    • Genetic susceptibility

    • Enviromental trigger

  2. Cell-mediated immune response against antigens in skin lesions

  3. Influx of macrophages and CD8 T lymphocytes

  4. Release of cytokines --> inflammation --> cell death

  5. Steven-Johnson Syndrome and toxic epidermal necrolysis are severe variant of Erythema multiforme associated with drug therapies.

Complications [kqq]

Epidemiology

Incidence per 100.000 [fnf]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Arthralgia, Cough, Fever, Headache, Malaise, Myalgia, Nausea, Sore throat

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Rash
Radiates
CaputCollumThoraxAbdomenGenitalArmBackLower bodyCavum oris (inside mouth)
Distribution
AsymmetricLocalizedMultipleSymmetric
Lesion type
ErythemaPlaqueUlcer
Lesion configuration
AnnularTarget lesion
Color
RedViolet

Approach

Erythema Multiforme

Stevens-Johnson syndrome

Toxic Epidermal Necrolysis

Treatment

  1. Acute phase --> Treat underlying disease: [kqq]

    • HSV infection: acyclovir 400 mg x 2 or valacyclovir 500 mg x 2

    • Mycoplasma pneumoniae infection

    • Drug-induced --> promptly discontinue

  2. Mild case: Complete healing in 3-6 weeks and the disease may recur

    • Anti-inflammatory: Fluocinonide 0.05% or other topical steroid agents

    • Analgesic agents

    • Mouthwash containing lidocaine and diphenhydramine

  3. Severe case:

    • Systemic steroids: Prednisone 40-60 mg/day, tapered over 2 to 4 weeks

    • Antiviral therapy (acyclovir, valacyclovir, or famciclovir)

    • Supportive care: liquid diet, intravenous fluids, electrolytes, and nutritional support

Differential diagnoses

Acute exanthematic pustulosis, Acute febrile neutrophilic dermatosis, Aphthous stomatitis, Behcet's disease, Bullous pemphigoid, Burn wound, Contact dermatitis, Drug eruptions, Erythroderma, Granuloma annulare, Herpes simplex, Lichen planus, Linear IgA dermatosis, Lyme disease, Meningitis, Mycoplasma infection, Necrotizing vasculitis, Pemphigus erythematosus, Pemphigus foliaceus, Pemphigus vulgaris, Pityriasis rosea, Sepsis, Serum sickness, Staphylococcal scalded skin syndrome, Stevens-Johnson syndrome, Syphilis, Systemic lupus erythematosus, Toxic epidermal necrolysis, Urticaria


References

[1] Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am. 2013 Oct;57(4):583-96.

[2] Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990 Jan;126(1):43-7.

[3] Hafsi W, Badri T. Erythema Multiforme. [Updated 2024 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470259/

[4] [Clinical Dermatology 4.th Edition by Weller, Hunter, Savin and Dahl]

[5] Hellgren L, Hersle K. Erythema multiforme: statistical eval- uation of clinical and laboratory data in 224 patients and matched healthy controls. Acta Allergologica. 1965;21:45-51.

[6] Ting HC, Adam BA. Erythema multiforme: epidemiology, clinical characteristics and natural history in fifty-nine patients. Australas J Dermatol. 1984;25:83-88.

[7] https://emedicine.medscape.com/article/1122915

Scroll to top